Neuronostatin
| Neuronostatin | |
|---|---|
| Identifiers | |
| Symbol | NST |
| IUPHAR | |
| CAS number | |
| HGNC | 11329 |
| OMIM | referenced 182450, referenced |
| RefSeq | associated with SST 6750, associated with SST |
| Other data | |
| Locus | Chr. 3 q27.3 |
Neuronostatin (abbreviated as NST) is a peptide hormone that may regulate portions of the endocrine system via interactions with G protein coupled receptor.
Neuronostatin is an alternative cleavage product of the preproprotein encoded by the somatostatin (SST) gene. Proteolytic processing of this precursor yields two distinct neuropeptides, with the specific products determined by tissue-dependent post-translational mechanisms. Neuronostatin is a linear, C-terminally amidated peptide that exists in forms of 13 or 19 amino acids in length. In contrast, somatostatin, another peptide derived from the same precursor, is structurally distinct, forming cyclic peptides of 14 or 28 amino acids. These differences arise from variations in cleavage sites and subsequent peptide modification, resulting in neuropeptides with unique amino acid sequences and conformations. Neuronostatin and somatostatin also differ in their biological distribution and relative abundance. Various tissues have been shown to express differing ratios of these peptides, reflecting tissue-specific regulation of SST gene processing and suggesting distinct physiological roles for each cleavage product.
Neuronostatin has been associated with impaired memory, increased Aβ presence and aggravated Aβ pathologies, kidney function and breast/prostate cancer metastasis
- Genes on human chromosome 3